期刊文献+

肿瘤靶向性药物载体叶酸-壳聚糖微球的制备及特性研究 被引量:13

Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier
在线阅读 下载PDF
导出
摘要 目的探索叶酸偶联壳聚糖(FA-CTS)纳米粒的合成方法及对肿瘤细胞的靶向性。方法利用叶酸活性酯与壳聚糖分子上的氨基反应形成稳定的酰胺键,制备FA-CTS。再利用壳聚糖在偏酸性溶液中带正电荷,在高速磁力搅拌作用下能与阴离子凝集的特性,将紫杉醇(PTX)做模型药物,制备负载PTX叶酸偶联壳聚糖(FA-CTS/PTX)纳米粒。采用荧光标记法和MTT法评价其肿瘤细胞靶向性。结果所制备的FA-CTS/PTX纳米粒,形态均质规则,无粘连,平均粒径282.8nm,包封率75.4%,载药量9.0%。荧光标记法结果表明FA-CTS纳米粒的肿瘤细胞亲和性均高于普通CTS纳米粒。MTT法结果显示FA-CTS/PTX纳米粒组的肿瘤细胞抑制率均高于普通CTS/PTX纳米粒组。结论合成的FA-CTS纳米粒可通过叶酸受体途径特异靶向于叶酸受体丰富的肿瘤细胞。 Objective To synthesize and characterize paclitaxel (PTX)-loaded folate-conjugated chitosan (FA-CTS/PTX) nanoparticles and evaluate its cytotoxicity in vitro. Methods CTS/PTX and FA-CTS/PTX nanoparticles were prepared using reductive amidation and ionic gelation ofchitosan with tripolyphosphate anions (TPP). The particle size was determined by laser scattering and the morphology observed using transmission electron microscopy, and the PTX content in the nanoparticles was determined using ultraviolet spectrophotometer at 227 nm. The in vitro cytotoxicity of the nanoparticles against HeLa cells was evaluated by MTT assay. Fluorescence microscopy was used to observe the HeLa cells incubated with FA-chitosan nanoparticles in the presence or absence of folic acid in the culture medium. Results PTX loading did not cause adhesion of the FA-CTS nanoparticles, which presented with uniform spherical morphology with an average diameter of 282.8 nm. The loading and encapsulation efficiencies of FA-CTS/PTX were 9.0% and 75.4%, respectively. The FA-CTS nanoparticles showed a greater extent ofintracellular uptake in the absence of folic acid, indicating that the cellular uptake of the nanoparticles occurred through endocytosis mediated by the folate receptors. The PTX-loaded FA-CTS nanoparticles exhibited potent cytotoxicity against HeLa cells, an effect 2- to 3-fold stronger than that of PTX-loaded CTS nanoparticles. Conclusion FA-CTS can be a promising drug carrier with high efficiency in condensing drug, good tumor-targeting ability and low cytotoxicity.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第12期2183-2186,共4页 Journal of Southern Medical University
关键词 叶酸偶联壳聚糖纳米粒 紫杉醇 纳米粒 药物载体 folate-conjugated chitosan nanoparticles paclitaxel nanoparticles drug carrier
  • 相关文献

参考文献10

  • 1Lu Y, Low PS. Folate-mediated delivery of macromolecular anticaneer therapeutic agents[J]. Adv Drug Deliv Rev, 2002, 54(5): 675-93.
  • 2Leamon CP, Low PS. Folate-mediated targeting: from diagnostics to drug and gene delivery[J]. Drug Discov Today, 2001, 6(1): 44-51.
  • 3Sinha VR, Singla AK, Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs[J]. Int J Pharm, 2004, 274(1-2): 1-33.
  • 4Senel S, McClure SJ. Potential applications of chitosan in veterinary medicine[J]. Adv Drug Deliv Rev, 2004, 56(10): 1467-80.
  • 5Synowiecki J, Al-Khateeb NA. Production, properties, and some new applications of chitin and its derivatives [J ]. Crit Rev Food Sci Nutr, 2003, 43(2): 145-71.
  • 6Mansouri S, Cuie Y, Winnik F et al. Characterization of folatechitosan-DNA nanoparticles for gene therapy [J]. Biomaterials, 2006, 27(9): 2060-5.
  • 7Wu Y, Yang WL, Wang CC, et al. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. International [J]. J Pharmaceutics, 2005, 295(1-2): 235-45.
  • 8吴振宇,陈钟,黄华,田鹏鹏.离子凝胶法制备壳聚糖纳米微粒[J].南通大学学报(医学版),2005,25(1):20-22. 被引量:14
  • 9Lu Y, Low PS. Folate-mediated delivery ofmacromolecular anticancer therapeutic agents[J ]. Adv Drug Deliv Rev, 2002, 54(5): 675-93.
  • 10Iyer AK, Khaled G, Fang J, et al. Exploiting the enhanced permeability and retention effect for tumor targeting [J]. Drug Discov Today, 2006, 11(17-18): 812-8.

二级参考文献10

  • 1Pan Y, Li YJ, Zhao HY,et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo[J].Int J Pharm,2002,249(1-2) : 139.
  • 2Mitra S,Gaur U,Ghosh PC,et al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier [J]. J Control Release,2001,74(1-3):317.
  • 3Corsi K,Chellat F,Yahia L. Fernandes JC. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J]. Biomaterials, 2003,24(7):1255.
  • 4van der Lubben IM, Verhoef JC,Borchard G,et al. Chitosan for mucosal vaccination [J]. Adv Drug Deliv Rev,2001,52(2):139.
  • 5Cairo P, Remunan-Lopez C, Vila-Jato JL, et al. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers [J]. J Appl Poly Sci, 1997, 63(1):25.
  • 6Sechriest VF, Miao Y J, Niyibizi C, et al. GAG- augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis[J]. J Biomed Mater Res,2000,49(4) :534.
  • 7Gong HP,Zhong YH,Li JC,et al. Studies on nerve cell affinity of chitosan-derived materials [J ]. J Biomed Mater Res,2000,52(2):285.
  • 8Tan W,Krishnaraj R,Desai TA. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering[J]. Tissue Eng, 2001,7 (2) : 203.
  • 9Bodmeier R,Chen HG ,Paeratakul O. A novel approach to the oral delivery of micro-or anoparticles [J].Pharm Res,1989,6(5): 413.
  • 10Gu HY,Chen Z,Sa RX,et al. The immobilization of hepatocytes on 24nm-sized gold colloid for enhanced hepatocytes proliferation [J ]. Biomaterials, 2004, 25(17):3445.

共引文献13

同被引文献145

引证文献13

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部